2016
DOI: 10.1016/j.neuint.2015.11.001
|View full text |Cite
|
Sign up to set email alerts
|

Neurodegenerative diseases: From available treatments to prospective herbal therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
63
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 102 publications
(64 citation statements)
references
References 93 publications
0
63
0
1
Order By: Relevance
“…Current pharmacological treatments for PD are symptomatic and associated with various side effects. Accumulating evidence has revealed the anti‐ageing and neuroprotective effects of natural products from traditional medicines, which may provide alternative therapies for neurodegenerative disorders including PD (Shen et al , ; Kim et al , ; Li et al , ; Islam et al , ; Solanki et al , ; Sun et al , ). Because targeting ALP has recently proposed as a promising strategy for PD and other neurodegenerative diseases (Menzies et al , ), the protective effects of genetically or pharmacologically activated ALP have been tested in experimental models of PD in recent years.…”
Section: Resultsmentioning
confidence: 99%
“…Current pharmacological treatments for PD are symptomatic and associated with various side effects. Accumulating evidence has revealed the anti‐ageing and neuroprotective effects of natural products from traditional medicines, which may provide alternative therapies for neurodegenerative disorders including PD (Shen et al , ; Kim et al , ; Li et al , ; Islam et al , ; Solanki et al , ; Sun et al , ). Because targeting ALP has recently proposed as a promising strategy for PD and other neurodegenerative diseases (Menzies et al , ), the protective effects of genetically or pharmacologically activated ALP have been tested in experimental models of PD in recent years.…”
Section: Resultsmentioning
confidence: 99%
“…These compounds may serve as active ingredients for novel therapies in the treatment of neurodegenerative diseases including Alzheimer's and Parkinson's disease [6]. Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, ALS, and Huntington's disease, are characterized by memory loss, irregular movement or behaviour and emotional difficulties due to a loss of neurons in the central nervous system [1,16]. Alzheimer's disease is a neurodegenerative disease in which beta-amyloid accumulates causing loss of memory which may result in dementia [11].…”
Section: Introductionmentioning
confidence: 99%
“…Parkinson's disease is a result of loss of dopaminergic receptor function, thereby reducing dopamine and causing symptoms, such as resting tremors and rigid limbs [17]. These neurodegenerative disorders may be caused by a combination of environmental, genetic, and age-related factors and can be treated using conventional drug therapies which are currently only moderately effective and often focus on symptom control not reversal or prevention of progression [16,8]. Oxidative stress is often a factor in neurodegenerative disease development and progression and can be remedied using antioxidant drugs, or natural compounds i.e., phenolic compounds including flavonoids and diarylheptanoids [3,1,18].…”
Section: Introductionmentioning
confidence: 99%
“…Intracellular neurofibrillary tangles (NFTs), extracellular senile plaque (SP), and abnormal cholinergic transmitter metabolism in the central nervous system (CNS) are pathological features observed in AD patients upon autopsy [1]. Hyperphosphorylation of tau is believed to account for most NFTs.…”
Section: Introductionmentioning
confidence: 99%